Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 725 of 1467 entries
View as:

Leflunomide in Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT00637819 Org: User:
Start: 01/31/03 End: 07/31/04 Due: 07/31/05

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Moderatetosevere Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT06609239 Org: User:
Start: 09/30/24 End: 01/20/31 Due: 01/20/32

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT05911763 Org: User:
Start: 06/30/23 End: 06/06/28 Due: 06/06/29

LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection

Phase: N/A Priority: Normal
NCT ID: NCT00906048 Org: User:
Start: 04/30/09 End: 04/30/10 Due: 04/30/11

Lactacyd Radiance (Lactic Acid) Prophetic Patch Test

Phase: N/A Priority: Normal
NCT ID: NCT00679562 Org: User:
Start: 03/31/08 End: - Due: -

Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03916601 Org: User:
Start: 12/13/17 End: 03/22/18 Due: 03/22/19

Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

Phase: N/A Priority: Normal
NCT ID: NCT03816839 Org: User:
Start: 03/25/19 End: 12/26/24 Due: 12/26/25

An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)

Phase: N/A Priority: Normal
NCT ID: NCT01161836 Org: User:
Start: 07/31/10 End: 06/30/11 Due: 06/30/12

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00134563 Org: User:
Start: 09/30/04 End: 07/31/10 Due: 07/31/11

Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years

Phase: N/A Priority: Normal
NCT ID: NCT03344029 Org: User:
Start: 11/03/17 End: 05/22/18 Due: 05/22/19

Acceptability Dermacyd Wipes - Lactoserum - Hygiene

Phase: N/A Priority: Normal
NCT ID: NCT00397527 Org: User:
Start: 07/31/06 End: - Due: -

Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00411229 Org: User:
Start: 06/30/06 End: 11/30/12 Due: 11/30/13

ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination

Phase: N/A Priority: Normal
NCT ID: NCT00708344 Org: User:
Start: 06/30/08 End: 07/31/09 Due: 07/31/10

Opposing Step-by-step Insulin Reinforcement to Intensified Strategy

Phase: N/A Priority: Normal
NCT ID: NCT00174642 Org: User:
Start: 12/31/04 End: - Due: -

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT00250614 Org: User:
Start: 04/30/05 End: 10/31/06 Due: 10/31/07

Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00521521 Org: User:
Start: 07/31/01 End: - Due: -

Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents

Phase: N/A Priority: Normal
NCT ID: NCT03434119 Org: User:
Start: 02/20/18 End: 01/07/19 Due: 01/07/20

CHOOSE : Telithromycin, Acute Bacterial Sinusitis

Phase: N/A Priority: Normal
NCT ID: NCT00174694 Org: User:
Start: 11/30/04 End: - Due: -

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00258739 Org: User:
Start: 10/31/01 End: - Due: -

ACT MALI: Treatment of Malaria Based on Combination Therapies

Phase: N/A Priority: Normal
NCT ID: NCT00452907 Org: User:
Start: 07/31/05 End: 06/30/07 Due: 06/30/08

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00284141 Org: User:
Start: 01/31/06 End: 07/31/08 Due: 07/31/09

Taxotere New Indication - Gastric Cancer Treatment Registration Trial

Phase: N/A Priority: Normal
NCT ID: NCT00811447 Org: User:
Start: 11/30/08 End: 06/30/12 Due: 06/30/13

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00694382 Org: User:
Start: 06/30/08 End: 11/30/10 Due: 11/30/11

Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01084252 Org: User:
Start: 05/11/10 End: 07/13/23 Due: 07/13/24

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00662870 Org: User:
Start: 05/31/01 End: 01/31/04 Due: 01/31/05